Cargando…

Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study

PURPOSE: Vaccination is an essential strategy to prevent infection in the SARS-CoV-2 pandemic. However, there are concerns about vaccine efficacy and the impact of vaccination on cancer treatment. Additionally, the emergence of novel variants may affect vaccination efficacy. This multi-center, prosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terada, Mitsuo, Kondo, Naoto, Wanifuchi-Endo, Yumi, Fujita, Takashi, Asano, Tomoko, Hisada, Tomoka, Uemoto, Yasuaki, Akiko Kato, Yamanaka, Natsumi, Sugiura, Hiroshi, Mita, Keiko, Wada, Asaka, Takahashi, Eriko, Saito, Kanako, Yoshioka, Ryo, Toyama, Tatsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360656/ https://www.ncbi.nlm.nih.gov/pubmed/35941421 http://dx.doi.org/10.1007/s10549-022-06693-2

Ejemplares similares

Granulocyte colony-stimulating factor-associated aortitis in a woman with breast cancer: a case report
por: Matsumoto, Nana, et al.
Publicado: (2022)

Discovering novel mechanisms of taxane resistance in human breast cancer by whole-exome sequencing
por: Wanifuchi-Endo, Yumi, et al.
Publicado: (2022)

Co-expression effect of LLGL2 and SLC7A5 to predict prognosis in ERα-positive breast cancer
por: Hisada, Tomoka, et al.
Publicado: (2022)

Fact-Checking Cancer Information on Social Media in Japan: Retrospective Study Using Twitter
por: Kureyama, Nari, et al.
Publicado: (2023)

Relapsed multiple myeloma manifesting as extramedullary plasmacytoma of the breast: Imaging findings
por: Urano, Misugi, et al.
Publicado: (2019)

Corrigendum to “Relapsed multiple myeloma manifesting as extramedullary plasmacytoma of the breast: Imaging findings” [Radiology Case Reports 14 (2019) 584–587]
por: Urano, Misugi, et al.
Publicado: (2020)

Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer
por: Sasada, Shinsuke, et al.
Publicado: (2023)

A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17)
por: Fukada, Ippei, et al.
Publicado: (2021)

Myoepithelial Carcinoma of the Breast Treated with Surgery and Chemotherapy
por: Endo, Yumi, et al.
Publicado: (2013)

A prediction model for distant metastasis after isolated locoregional recurrence of breast cancer
por: Murata, Takeshi, et al.
Publicado: (2023)

Exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach
por: Tan, Wei Shen, et al.
Publicado: (2020)

Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy
por: Iwata, Hiroji, et al.
Publicado: (2023)

Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer
por: Elliott, Daisy, et al.
Publicado: (2018)

Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer
por: D'Andrea, David, et al.
Publicado: (2019)

CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer
por: Mostafid, A. Hugh, et al.
Publicado: (2020)

Ultra‐hypofractionated radiation therapy for unfavourable intermediate‐risk and high‐risk prostate cancer is safe and effective: 5‐year outcomes of a phase II trial
por: Macias, Victor A., et al.
Publicado: (2019)

A multicenter phase I study of preoperative chemoradiotherapy with S-1 and irinotecan for locally advanced lower rectal cancer (SAMRAI-1)
por: Sato, Takeo, et al.
Publicado: (2016)

Glycoprotein Hyposialylation Gives Rise to a Nephrotic-Like Syndrome That Is Prevented by Sialic Acid Administration in GNE V572L Point-Mutant Mice
por: Ito, Mitutoshi, et al.
Publicado: (2012)

Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study
por: Iwata, Hiroji, et al.
Publicado: (2018)

Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertension
por: Rakugi, Hiromi, et al.
Publicado: (2014)

Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial
por: Masuda, Norikazu, et al.
Publicado: (2021)

Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry
por: Iwamoto, Takayuki, et al.
Publicado: (2016)

A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer
por: Masuda, Norikazu, et al.
Publicado: (2020)

Randomized clinical trial of high versus low inferior mesenteric artery ligation during anterior resection for rectal cancer
por: Fujii, S., et al.
Publicado: (2018)

TIGIT-based immunotherapeutics in lung cancer
por: Patel, Akshay J, et al.
Publicado: (2023)

Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer
por: Endo, Yumi, et al.
Publicado: (2014)

Risk of secondary malignancy after radiotherapy for breast cancer: long-term follow-up of Japanese patients with breast cancer
por: Okonogi, Noriyuki, et al.
Publicado: (2022)

Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life
por: Wyld, Lynda, et al.
Publicado: (2021)

Prognostic impact of breast cancer subtypes in elderly patients
por: Bergen, E. S., et al.
Publicado: (2016)

The efficacy of lymphaticovenular anastomosis in breast cancer-related lymphedema
por: Winters, H., et al.
Publicado: (2017)

Preventative therapy for breast cancer: a clinical experience
por: Law, Rebekah, et al.
Publicado: (2023)

The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers
por: Anderson, Karen S., et al.
Publicado: (2022)

The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression
por: Bryant, Richard J., et al.
Publicado: (2020)

In‐hospital cost analysis of prostatic artery embolization compared with transurethral resection of the prostate: post hoc analysis of a randomized controlled trial
por: Müllhaupt, Gautier, et al.
Publicado: (2019)

Concurrent Chemoradiotherapy without Brachytherapy in Locally Advanced Cervical Cancer
por: Kadkhodayan, Sima, et al.
Publicado: (2013)

Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients
por: Binkhorst, Lisette, et al.
Publicado: (2015)

Trial watch: Toll-like receptor ligands in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2023)

Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer
por: Inoue, Yuka, et al.
Publicado: (2022)

Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer
por: Sanft, Tara, et al.
Publicado: (2015)

The impact of high-intensity interval exercise training on NK-cell function and circulating myokines for breast cancer prevention among women at high risk for breast cancer
por: Coletta, Adriana M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_87aan5leag3j0kuisgc6nkt14e